Biotech: claim tax relief on your innovative projects - Leyton Germany

Did you know that you can have costs already incurred for your innovative projects funded retroactively?

Claim tax relief on your innovative projects, are you maximising your claims potential?

Find out today!

Is your business benefitting from valuable R&D Tax Credits?

R&D in Biotech

The significant financial investment required in order to launch a new biotechnology product can make the journey to viable launch and scale-up challenging. In order to encourage investment in biotech and maintain Germany’s position as a hub of innovation in this industry, the German government provides considerable tax relief for businesses who are innovating in this sector. Biotech companies are well positioned to be eligible for R&D Tax Credits as innovation is constantly being performed during the development process. This tax relief can help offset costs such as staff salaries or third party contracts.

Examples of qualifying R&D projects in Biotech

Reformulating an existing drug to reduce side effects or dosage Developing new or improved pharmaceuticals, biologics or medical devices
Developing methods to increase shelf life of a product
Development of novel software systems for use in research and clinical development
Improving the manufacturing process of a drug
Developing new uses for existing drugs
It is important that all innovations must be better than the current state of the art and must have a technical risk

We understand the topics that drive your industry

In the field of industry (“white” bio/genetic engineering): optimization/realization of industrial processes for the production of biogenic substances: Food supplements (e.g. vitamins), technically usable enzymes (e.g. detergents), novel biogenic energy sources (substitutes for fossil energy sources), bio-plastics;
In the field of agriculture/nutrition (“green” bio/genetic engineering): optimization of (industrial) processes (e.g. breeding research, plant and animal breeding) to adapt agriculture to climate change;
In the field of health (“red” bio/genetic engineering): development of new tools, such as RNA-based vaccines or CRISPR-Cas method for genome editing, in order to open up new areas of use and possible applications in the fields of analysis, diagnostics, gene/cancer therapy;
In the field of health (“red” bio/genetic engineering): development of effective(er) therapies of individualized medicine.

Talk to our experts

Anrede

Vor- und Nachname*

Unternehmen*

E-mail*

Tel.-Nr*

Mit der Auswahl von “Senden” bestätige ich, dass ich die Datenschutzerklärung gelesen, verstanden und akzeptiert habe

How we help.

Many companies in the sector are not aware that they carry out eligible R&D activities on a day-to-day basis within the meaning of the research allowance, for which they can claim a lucrative tax credit. The tax credit is offset against a company’s income tax liability and allows reinvestment in further R&D, for example.

Our Leyton experts assist companies in applying for the research grant. Our dedicated team consists of experienced engineers and scientists who provide our biotechnology clients with maximum economic benefits as well as significantly contribute to optimizing operating costs.